CCBE1 anticorps (AA 201-300)

N° du produit ABIN872842

Détail du produit anti-CCBE1 anticorps

Antigène: CCBE1 (Collagen and Calcium Binding EGF Domains 1 (CCBE1))

Épitope: AA 201-300

Reactivité: Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CCBE1 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Réactivité croisée: Souris

Homologie: Human,Rat,Dog,Pig,Horse

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human CCBE1

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Date de péremption: 12 months

Détails sur CCBE1

Antigène: CCBE1 (Collagen and Calcium Binding EGF Domains 1 (CCBE1))

Autre désignation: CCBE1 (CCBE1 Produits)

Synonymes: anticorps 4933426F18Rik, anticorps 9430093N24Rik, anticorps mKIAA1983, anticorps RGD1307670, anticorps fof, anticorps collagen and calcium binding EGF domains 1, anticorps CCBE1, anticorps Ccbe1, anticorps ccbe1

Sujet:

Synonyms: CCBE 1, ccbe1, CCBE1_HUMAN, Collagen and calcium binding EGF domain containing protein 1, Collagen and calcium binding EGF domains 1, Collagen and calcium-binding EGF domain-containing protein 1, Full of fluid protein homolog.

Background: This gene is thought to function in extracellular matrixremodeling and migration. It is predominantly expressed in theovary, but down regulated in ovarian cancer cell lines and primarycarcinomas, suggesting its role as a tumour suppressor. Mutationsin this gene have been associated with Hennekamlymphangiectasia-lymphedema syndrome, a generalized lymphaticdysplasia in humans. [provided by RefSeq, Mar 2010].

ID gène: 147372